Fumonisin B1 Analysis: Testing Methods, Samples, and Regulatory Guidance

Fumonisin B1 (FB1) analysis is a critical component of mycotoxin testing programs for maize, cereal products, and animal feed, protecting food safety and supporting regulatory compliance worldwide. This technical guide explains the chemistry and toxicology of fumonisin B1, the sample types and analytes involved, and the principal analytical methods—from HPLC-FLD and LC-MS/MS to ELISA screening—used by accredited laboratories.

Technical Overview

Fumonisin B1 (FB1) is the most abundant and most toxic member of the fumonisin family of mycotoxins, produced primarily by the fungi Fusarium verticillioides and Fusarium proliferatum, which colonize maize crops in the field and during storage. FB1 contamination is reported in maize-growing regions worldwide, with frequency and severity driven by warm temperatures, drought stress, and insect damage to kernels.

Chemically, FB1 (C34H59NO15, molecular weight 721.8 g/mol) is a long-chain aminopolyol backbone esterified with two tricarballylic acid groups. The molecule is highly polar and amphoteric, carrying a primary amine and four carboxyl groups. Importantly for analysts, FB1 lacks a strong chromophore and exhibits no native fluorescence, which dictates the use of derivatization or mass spectrometric detection.

Toxicologically, FB1 structurally resembles sphingoid bases and inhibits ceramide synthase, disrupting sphingolipid metabolism and elevating free sphinganine in blood and urine—a widely used biomarker of exposure. The International Agency for Research on Cancer (IARC) classifies FB1 as Group 2B (possibly carcinogenic to humans). In animals, FB1 causes equine leukoencephalomalacia in horses, porcine pulmonary edema in swine, and liver and kidney toxicity across species. Epidemiological studies associate high dietary exposure with esophageal cancer and neural tube defects.

FB1 is remarkably heat-stable and survives most milling, baking, and extrusion processes. Alkaline cooking, such as nixtamalization, hydrolyzes the tricarballylic esters to form hydrolyzed FB1 (HFB1), which remains biologically active. Contamination is not uniform: FB1 concentrates in the bran and germ fractions and is typically elevated roughly threefold in maize distillers dried grains with solubles (DDGS) compared with the parent grain.

Testing Samples

Cereal Grains and Milled Products

Raw and milled cereals represent the highest-volume sample category. Typical matrices include:

• Whole-kernel maize, including dent corn, popcorn, and sweet corn
• Maize meal, maize flour, grits, polenta, and corn starch
• Maize bran, germ, and dry-milled fractions
• Other cereals such as sorghum, rice, wheat, and barley when Fusarium contamination is suspected

Processed Foods

Finished foods are tested to verify that processing and ingredient dilution have brought contamination within regulatory limits. Common matrices include:

• Breakfast cereals and cornflakes
• Tortillas, tortilla chips, and extruded snacks
• Infant cereals, baby foods, and processed maize-based foods for young children
• Beer and other maize-derived beverages
• Gluten-free products, which frequently rely on maize as a primary ingredient

Animal Feed and Feed Ingredients

Because livestock species differ widely in fumonisin sensitivity, feeds are tested and segregated by intended use:

• Complete feeds for horses, rabbits, swine, poultry, ruminants, and aquaculture species
• Maize by-products including DDGS, corn gluten meal, and germ meal
• Silage and stored forage

Biological Matrices

In human and animal exposure studies, laboratories analyze serum, urine, and tissues for urinary FB1 and the sphinganine-to-sphingosine ratio, supporting biomonitoring, epidemiology, and toxicology programs.

Testing Items

Testing scopes are structured around regulatory definitions and scientific objectives. Core testing items include:

• Fumonisin B1 (FB1) quantification as a single analyte
• Fumonisins B2 and B3 (FB2, FB3) individually determined
• Total fumonisins, reported as the sum of FB1, FB2, and FB3 per FDA guidance, or FB1 plus FB2 per EU and Codex maximum levels
• Hydrolyzed fumonisin B1 (HFB1) and modified or masked fumonisins in processed products
• Biomarkers of exposure, including urinary FB1 and the sphinganine/sphingosine ratio
• Assessment of results against applicable FDA, EU, Codex, and national statutory limits

Testing Methods

Sample Extraction and Cleanup

FB1 is extracted from homogenized samples with acetonitrile–water (50:50) or methanol–water (75:25) by shaking for 30 to 60 minutes, followed by filtration. For HPLC-fluorescence methods, the extract is conditioned to near-neutral pH and passed through an immunoaffinity column (IAC) containing monoclonal anti-fumonisin antibodies. The column is washed, eluted with methanol, and the eluate is evaporated and reconstituted for analysis. For LC-MS/MS multi-analyte panels, cleanup may be simplified to dispersive SPE or dilute-and-shoot protocols with matrix-matched calibration.

HPLC with Fluorescence Detection (HPLC-FLD)

HPLC-FLD remains the workhorse for single-group fumonisin determination. Because FB1 lacks native fluorescence, the primary amine is derivatized pre-column with o-phthalaldehyde (OPA) combined with 2-mercaptoethanol or N-acetyl-L-cysteine. The OPA derivative is unstable, so derivatized extracts must be injected within minutes under strictly timed conditions. Separation uses a C18 column with a methanol–phosphate buffer mobile phase (pH approximately 3.3 to 3.5), with fluorescence detection at 335 nm excitation and 440 nm emission. Typical limits of quantification range from 25 to 50 µg/kg. Recognized official methods include AOAC 995.15 (corn), AOAC 2001.04 (cornflakes), and EN 14352 (cereals).

Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS)

LC-MS/MS is the preferred confirmatory technique. Using electrospray ionization in positive mode, FB1 forms the protonated precursor ion at m/z 722.4, with characteristic product ions at m/z 334.3 (quantifier) and 352.4 or 370.3 (qualifiers). Isotope dilution with carbon-13-labeled FB1 internal standard corrects for matrix effects and recovery losses. Modern LC-MS/MS platforms quantify FB1 alongside hundreds of other mycotoxins in a single run, achieve limits of quantification of 1 to 5 µg/kg, and provide the highest confidence for regulatory enforcement and complex processed matrices.

ELISA and Rapid Screening Tests

Competitive ELISA kits in 96-well format deliver semi-quantitative results within one hour at low cost, making them suitable for intake screening and high-throughput grain surveys. Lateral flow devices with portable readers enable on-site testing at elevators, mills, and receiving points. Screening positives must be confirmed by HPLC-FLD or LC-MS/MS before regulatory or commercial decisions are finalized. AOAC 2001.06 provides an official ELISA method for cornflakes.

Method Validation and Quality Control

Accredited laboratories validate methods against performance criteria such as those in EC Regulation 401/2006 and Codex guidelines, typically demonstrating recoveries of 70 to 110 percent and repeatability RSD below 20 percent in the relevant concentration range. Quality assurance measures include matrix-matched or isotope-dilution calibration, certified reference materials, spiked recovery controls with each batch, and regular participation in proficiency testing schemes such as FAPAS.

Applications

Fumonisin B1 analysis supports a broad range of safety, commercial, and scientific objectives:

• Regulatory compliance testing of foods and feeds against national and international maximum levels
• Import and export inspection for grain trade, including lot acceptance and segregation decisions
• Feed safety programs protecting horses, swine, poultry, and aquaculture species with differing sensitivity thresholds
• HACCP and process control in milling and food manufacturing, including tracking of FB1 distribution across millstreams and by-products
• Human biomonitoring and epidemiological studies of dietary mycotoxin exposure
• Agricultural research on Fusarium resistance, kernel infection, and storage management
• Development and validation of analytical methods, reference materials, and proficiency testing schemes

FAQ

What is the difference between fumonisin B1 and total fumonisins?

FB1 typically accounts for 70 to 80 percent of total fumonisins in contaminated maize, with FB2 and FB3 contributing most of the remainder. FDA guidance levels for foods and feeds are based on the sum of FB1, FB2, and FB3, while EU and Codex maximum levels are defined as FB1 plus FB2. Reporting conventions must therefore match the applicable regulation.

What regulatory limits apply to fumonisin B1?

Under FDA guidance, human corn-based foods are limited to 2 to 4 ppm total fumonisins depending on the degree of degerming, with 3 ppm for popcorn. EU maximum levels for FB1 plus FB2 range from 4000 µg/kg in unprocessed maize down to 200 µg/kg in processed maize-based foods for infants and young children. Codex sets 4000 µg/kg for raw maize and 2000 µg/kg for maize flour and meal. Always verify current requirements for your market and product category.

Why is derivatization required for HPLC analysis of FB1?

FB1 contains no native fluorophore or strong UV chromophore. Reagents such as OPA react with the primary amine of FB1 to form a fluorescent adduct detectable at low microgram-per-kilogram levels. Because the derivative degrades rapidly, automated or strictly timed derivatization and injection are essential for reproducible results.

How stable is fumonisin B1 in samples?

FB1 is highly stable during drying, milling, and long-term frozen storage. To preserve sample integrity, dry grain below approximately 13 percent moisture to prevent further fungal growth, store milled samples cold or frozen, and avoid repeated freeze-thaw cycles. Additional mold growth in improperly stored samples can increase toxin levels and invalidate results.

Which analytical method should be chosen?

Use ELISA or lateral flow tests for rapid, low-cost screening at intake or on site; use HPLC-FLD with immunoaffinity cleanup for routine, single-group compliance testing; and use LC-MS/MS when lowest detection limits, multi-mycotoxin coverage, complex processed matrices, or definitive regulatory confirmation are required. A tiered screening-plus-confirmation strategy offers the best balance of speed, cost, and certainty.